CVS Health Corp (CVS)

Schlusskurs vom Vortag:

$67.33

Offen:

$67.21

24-Stunden-Volumen:

6.32M

Marktkapitalisierung:

$84.68B

Einnahmen:

$357.78B

Nettoeinkommen (Verlust:

$8.34B

KGV:

10.13

EPS:

6.63

Netto-Cashflow:

$10.40B

1W Leistung:

-3.68%

1M Leistung:

-15.31%

6M Leistung:

-1.18%

1J Leistung:

-7.03%

1-Tages-Spanne:

$66.75

$67.42

52-Wochen-Spanne:

$64.41

$83.25

CVS Health Corp Stock (CVS) Company Profile

Firmenname

CVS Health Corp

Sektor

Healthcare (1191)

Branche

Healthcare Plans (13)

Telefon

401-765-1500

Adresse

One CVS Drive, Woonsocket

Mitarbeiter

160,000

Twitter

@cvshealth

Nächster Verdiensttermin

2024-05-16

Neueste SEC-Einreichungen

CVS's Discussions on Twitter

CVS Health Corp Stock (CVS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-03-06	Eingeleitet	Barclays	Equal Weight
2024-02-26	Eingeleitet	Leerink Partners	Outperform
2023-12-22	Eingeleitet	HSBC Securities	Buy
2023-09-19	Hochstufung	Evercore ISI	In-line → Outperform
2023-09-12	Hochstufung	Wolfe Research	Peer Perform → Outperform
2023-08-18	Herabstufung	Edward Jones	Buy → Hold
2023-05-26	Eingeleitet	Piper Sandler	Overweight
2023-04-21	Eingeleitet	Cantor Fitzgerald	Overweight
2023-01-03	Herabstufung	Evercore ISI	Outperform → In-line
2022-11-23	Fortgesetzt	Morgan Stanley	Overweight
2022-06-17	Eingeleitet	Loop Capital	Buy
2022-05-27	Herabstufung	Bernstein	Outperform → Mkt Perform
2022-03-29	Herabstufung	Deutsche Bank	Buy → Hold
2022-02-11	Herabstufung	Raymond James	Strong Buy → Outperform
2021-12-14	Eingeleitet	Goldman	Buy
2021-12-01	Eingeleitet	Seaport Research Partners	Buy
2021-05-19	Eingeleitet	Wells Fargo	Equal Weight
2021-03-17	Herabstufung	Guggenheim	Buy → Neutral
2021-01-08	Hochstufung	Jefferies	Hold → Buy
2020-09-17	Eingeleitet	Piper Sandler	Overweight
2020-07-01	Eingeleitet	SVB Leerink	Mkt Perform
2020-05-14	Hochstufung	Credit Suisse	Neutral → Outperform
2019-09-27	Fortgesetzt	RBC Capital Mkts	Outperform
2019-09-12	Eingeleitet	Deutsche Bank	Buy
2019-06-05	Hochstufung	Standpoint Research	Hold → Buy
2019-04-29	Herabstufung	Credit Suisse	Outperform → Neutral
2019-04-18	Eingeleitet	Guggenheim	Buy
2019-04-15	Herabstufung	Oppenheimer	Outperform → Perform
2019-04-10	Bestätigt	BofA/Merrill	Buy
2019-03-13	Eingeleitet	Bernstein	Outperform
2019-02-20	Herabstufung	Wells Fargo	Outperform → Market Perform
2019-01-17	Eingeleitet	UBS	Buy
2018-12-18	Eingeleitet	Barclays	Overweight
2018-11-29	Fortgesetzt	Goldman	Neutral
2018-11-28	Eingeleitet	Evercore ISI	Outperform
2018-10-26	Fortgesetzt	Wolfe Research	Peer Perform
2018-07-09	Hochstufung	Citigroup	Neutral → Buy
2018-02-27	Fortgesetzt	BofA/Merrill	Buy
2018-02-13	Bestätigt	Citigroup	Neutral

Alle ansehen

CVS Health Corp Aktie (CVS) Neueste Nachrichten

CVS Health (CVS) Stock Drops Despite Market Gains: Important Facts to Note

Zacks Investment Research

Gear Up for CVS Health (CVS) Q1 Earnings: Wall Street Estimates for Key Metrics

Zacks Investment Research

Why CVS Health (CVS) Dipped More Than Broader Market Today

Zacks Investment Research

3 Absurdly Cheap Stocks to Buy and Hold for Years

The Motley Fool

Earnings Preview: CVS Health (CVS) Q1 Earnings Expected to Decline

Zacks Investment Research

Wall Street Analysts Think CVS Health (CVS) Is a Good Investment: Is It?

Zacks Investment Research

Finanzdaten der CVS Health Corp-Aktie (CVS)

CVS Health Corp (CVS) Umsatz 2024

CVS Health Corp (CVS) Nettogewinn 2024

CVS Health Corp (CVS) Free Cashflow 2024

CVS Health Corp (CVS) Gewinn je Aktie 2024

CVS Health Corp-Aktie (CVS) Insiderhandel